A phase I study of the AKT inhibitor MK-2206 in combination with hormonal therapy in postmenopausalwomenwith estrogen receptor-positive metastatic breast cancer

Cynthia X. Ma, Cesar Sanchez, Feng Gao, Robert Crowder, Michael Naughton, Timothy Pluard, Allison Creekmore, Zhanfang Guo, Jeremy Hoog, Craig Lockhart, Austin Doyle, Charles Erlichman, Matthew J. Ellis

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I study of the AKT inhibitor MK-2206 in combination with hormonal therapy in postmenopausalwomenwith estrogen receptor-positive metastatic breast cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences